Complete Guide to Tablet Friability Testing (USP <1216>)
Share
A batch fails the friability test with a result of 1.2%. The formulation team points out that hardness is within specification. The QC director knows neither argument matters: USP <1216> sets a single threshold of 1.0%. There is no gray zone.
Friability testing looks straightforward. In practice, it is one of the physical tablet tests most easily executed incorrectly — and most difficult to defend in an FDA audit when procedures are ambiguous.
For laboratories using the CJY-300E Friability Tester or evaluating equipment options, this guide covers the complete protocol per USP <1216>, the most common industry execution errors, and equipment selection criteria.
The Real Problem: Why Labs Keep Failing Friability Audits
Friability testing does not fail because labs are unfamiliar with the method. It fails because of execution details that appear minor but are determinative in a regulatory inspection.
The three most common failures in documented audits:
- Incorrect sample weight: USP <1216> requires approximately 6.5 g of tablets — specifically, the number of whole tablets nearest to 6.5 g without exceeding 10 units. Using exactly 10 units without verifying weight introduces systematic bias in batches with high individual mass variability.
- Speed deviation: The drum must rotate at 25 ± 1 RPM for exactly 4 minutes (100 revolutions). A ±2 RPM deviation alters the impact profile and can shift the result by 0.1–0.3 percentage points.
- Inconsistent dedusting: The pharmacopoeia requires dedusting (removal of fine powder) before the initial weighing. If dedusting is not standardized in the SOP, residual fine powder artificially inflates the calculated mass loss.
None of these errors are visible on the instrument. They are procedural errors that an FDA auditor identifies by reviewing execution records and comparing them against the validated SOP.
Complete Technical Protocol per USP <1216>
Sample Preparation
- Tablet selection: Select tablets without visible defects (cracks, chips, lamination). Tablets with pre-existing defects distort the result.
- Initial dedusting: Remove fine powder with a soft brush or appropriate sieve for 30 seconds. Document the method used in the test record.
- Initial weighing (W₀): Weigh the tablet set with a resolution of 0.001 g. For tablets with individual weight ≥ 650 mg, the alternative USP method allows a single unit.
- Loading the drum: Place tablets into the friability tester drum. USP defines drum geometry (165–170 mm interior diameter, 1.8 mm paddle depth) to ensure reproducibility across instruments and laboratories.
Test Conditions
| Parameter | USP <1216> Value |
|---|---|
| Rotation speed | 25 ± 1 RPM |
| Number of revolutions | 100 (4 minutes) |
| Sample weight | ~6.5 g (or the nearest whole number ≤ 10 units) |
| Laboratory temperature | 25 °C ± 2 °C recommended |
| Relative humidity | Controlled if the formulation is hygroscopic |
Calculation and Interpretation
Friability formula:
F (%) = [(W₀ − W₁) / W₀] × 100
Where W₀ = initial weight and W₁ = final weight after post-test dedusting.
USP <1216> acceptance criterion: F ≤ 1.0%
If any tablet breaks during the test (visible fracture, not simple surface erosion), the batch is considered failed regardless of the calculated percentage value.
Repeat testing: If the result falls between 0.8% and 1.0%, many laboratories perform a second determination by duplicate. USP does not explicitly require this, but it is recommended practice before making a disposition decision.
Environmental Condition Control
For formulations with hygroscopic components (mannitol, amorphous lactose, HPMC), relative humidity during the test directly affects the result. A laboratory running the test at 45% RH versus one running at 65% RH will obtain different friability values for the same formulation. If the SOP does not specify environmental conditions, results across shifts or laboratories are not comparable.
Decision Framework: When to Use a Standalone Tester vs. a 4-in-1 System
For QC laboratories conducting multiple physical tablet tests, the choice between a standalone friabilimeter and an integrated system directly affects workflow efficiency and available bench space.
| Laboratory Scenario | Recommendation |
|---|---|
| Friability only in routine testing, < 5 batches/week | CJY-300E standalone |
| Friability + hardness + disintegration + dissolution in same workflow | SY-6DN 4-in-1 |
| Laboratory with limited bench space (< 2 m²) | SY-6DN 4-in-1 |
| Laboratory requiring electronic data export | SY-6DN (CJY-300E is visual observation only, no data output) |
| Best for high-volume friability on production line | CJY-300E (adjustable speed, compact design) |
Critical note on the CJY-300E: This instrument is visual observation only. It does not generate digital data, does not print records, and has no data output. If the laboratory SOP requires electronic records of friability results, operators must manually transcribe the observed values. This limitation must be documented in the method validation plan.
The Huanghai Solution: CJY-300E and SY-6DN
CJY-300E — Tablet Friability Tester
The CJY-300E is the standard instrument for friability testing in pharmaceutical QC laboratories:
- Adjustable speed: Configurable to meet exactly the 25 ± 1 RPM required by USP <1216>
- Simplified touchscreen interface: Reduces operator configuration errors
- Compact design: 18.5 kg — suitable for laboratory benches with limited space
- Direct visual observation: Transparent drum allows monitoring of tablet behavior during the test
- No data output: Records are documented manually — this point must be included in the validated SOP
SY-6DN — Intelligent 4-in-1 Analyzer
For laboratories that need to integrate friability testing with other physical tablet tests, the SY-6DN combines in a single instrument:
- Hardness testing
- Friability testing
- Disintegration testing
- Dissolution testing
The SY-6DN does not measure tablet diameter or thickness — its function is exclusively the combination of these four pharmaceutical tests. For laboratories with QC workflows requiring all four determinations on the same batch, the SY-6DN eliminates sample transfer times between instruments and reduces the required bench space.
Frequently Asked Questions
Q: How many tablet units are used in the friability test per USP <1216>?
A: USP <1216> requires a sample of approximately 6.5 g. In practice, this means selecting the number of whole tablets whose combined weight is nearest to 6.5 g without exceeding 10 units. For tablets with individual weight ≥ 650 mg, the alternative method allows a single unit. Do not always use a fixed 10 units without verifying weight — this introduces systematic bias in the determination. The Huanghai CJY-300E allows correct sample loading per this protocol. Contact us at drugmachines.com/pages/contact for instrument specifications.
Q: Does the CJY-300E support FDA data integrity (ALCOA+) requirements?
A: The CJY-300E executes the USP <1216> test protocol (25 ± 1 RPM, 100 revolutions) but is a visual observation instrument with no electronic data output. Laboratories under FDA regulation that require time-stamped electronic records, audit trails, and electronic signatures should document the manual transcription process in their SOPs, or evaluate the SY-6DN 4-in-1 — which integrates friability with audit trail and structured data export — for workflows requiring greater traceability. Huanghai lab instruments support basic audit trails per USP/ChP.
Q: What is the difference between the CJY-300E and the SY-6DN friability module?
A: The CJY-300E is a standalone instrument dedicated exclusively to friability testing, with a compact design (18.5 kg) and straightforward operation for production QC laboratories. The SY-6DN is a 4-in-1 system that integrates friability, hardness, disintegration, and dissolution in a single platform — designed for laboratories performing multiple physical determinations in the same QC workflow. The choice depends on testing volume and whether the laboratory requires the other three functions integrated. The SY-6DN does not measure tablet diameter or thickness.
Q: What does a 0.9% friability result mean in terms of batch risk?
A: A 0.9% result meets the USP <1216> acceptance criterion (≤ 1.0%), but leaves a margin of only 0.1 percentage points. In long-running production, a formulation consistently scoring 0.8–0.9% may exceed the threshold if there is variability in granulation or compression conditions. Formulation and QC teams should treat these values as an early warning signal and review process parameters before an actual failure occurs — not after. For equipment consultation, contact the Huanghai team at drugmachines.com/pages/contact.
Q: Can the friability test be performed on coated tablets using the CJY-300E?
A: Yes, with SOP-level clarification. USP <1216> applies to uncoated tablets as the standard case. For tablets with functional coatings (modified-release), the friability test may compromise coating integrity in ways that do not reflect real distribution conditions. The SOP must specify whether the test applies before or after coating, and the choice must be justified to the regulatory authority. The CJY-300E accommodates both pre- and post-coating test scenarios — the distinction is procedural, not instrumental.
Conclusion
For pharmaceutical QC laboratories managing friability testing under USP <1216>, correct protocol execution — exact sample weight, 25 ± 1 RPM, standardized dedusting, documented environmental conditions — is what differentiates a defensible result from one that generates audit observations. The 1.0% threshold has no tolerance band: operational precision is not optional.
For laboratories that need only the friability determination, the CJY-300E provides the complete protocol in a compact, straightforward-to-operate format. For laboratories integrating friability with hardness, disintegration, and dissolution in the same workflow, the SY-6DN 4-in-1 consolidates all four determinations on a single platform.
Explore the CJY-300E → | Explore the SY-6DN →
Questions about equipment selection or compatibility with your current SOP? Contact the Huanghai team.